期刊文献+

年轻乳腺癌患者生存率分析 被引量:9

Analysis of the Survival Rate for Young Patients with Breast Cancer
下载PDF
导出
摘要 目的探讨1980年~1984年(简称1980组)和1994年~1996年(简称1994组)两组年轻乳腺癌患者(≤35岁)生存状况的变化及其相关临床因素。方法回顾性分析≤35岁原发性乳腺癌179例,均随访5年,随访率100.0%,比较两组生存率并探讨临床病理因素对生存率的影响。结果1980组和1994组5年生存率分别为59.8%(52/87)、78.3%(72/92),5年健在率分别为51.7%(45/87)、75.0%(69/92),两组比较有显著性差异(P〈0.01)。1994组Ⅰ、Ⅱ期病例及淋巴结阴性率均高于1980组(79.4%,60.9%,P〈0.01和59.8%,42.5%,P〈0.05),并且生存率改善主要为Ⅰ、Ⅱ期病例。1994组行保乳手术例数明显增加,行经典根治术例数减少(P〈0.01)。结论1994组年轻乳腺癌生存率显著改善,手术范围扩大不体现生存优势,提高生存率的关键是早期诊断及治疗,并非完全依赖治疗手段。 Objective To study the changes in survival and the relative clinical factors in two cohorts of young patients with breast cancer ( ≤ 35-year-old) between 1980 - 1984 (1980s) and 1994 - 1996 (1990s). Methods The data of 179 patients with primary breast cancer ( ≤ 35-year-old) were analyzed retrospectively. The patients were followed for 5 years with a follow-up rate of 100.0%. The survival rate in two cohorts was compared and the influence of the clinicopathological factors on survival was analyzed. Results The 5-year survival rate in 1980s and 1990s were 59.8% (52/87) ,78.3% (72/92) ,respectively, and the 5-year disease-free survival rate were 51.7% (45/87) and 75.0% (69/92), which were significantly different (P 〈 0.01 ). The proportion of stage Ⅰ , Ⅱ and node-negative in 1990s was higher than that in 1980s (79.4% VS 60.9%,P 〈 0.01 and 59.8% VS 42.5% ,P 〈0.05). The patients with stage Ⅰ , Ⅱ had a better survival rate. The rates of breast-conserving therapy increased dramatically in 1990s( P 〈 0.01 ). Conclusion The survival rate for young patients with breast cancer has significantly improved in 1990s. Extended operations do not benefit the survival. The improvement of survival is mostly based on early diagnosis and treatment.
作者 孟洁 张瑾
出处 《实用癌症杂志》 2008年第5期486-488,495,共4页 The Practical Journal of Cancer
基金 天津医科大学科学基金(2004KY48)资助
关键词 乳腺癌 生存率 临床因素 Breast cancer Survival rate Clinical factor
  • 相关文献

参考文献8

  • 1Asa J, Donna N, Daniel F, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast eaneer[J]. J Clin Oneol, 1994,12: 888. 被引量:1
  • 2David P, Winchester MD. Breast cancer in young women [ J ]. Surgical Clinics of North America, 1996,76:279. 被引量:1
  • 3张京泰,黄信孚,高非.青年乳腺癌的临床分析[J].中国肿瘤临床,1997,24(11):835-837. 被引量:30
  • 4陈伟国,李健文,朱丽,李亚芬,朱建新.157例35岁以下女性乳腺癌的预后分析[J].肿瘤,2001,21(2):135-137. 被引量:16
  • 5徐晓明,黄晓蓉,易瑛,辜艳.78例青年人乳腺癌临床分析[J].四川肿瘤防治,2001,14(4):216-217. 被引量:3
  • 6Qinghua X, Vicente V, Vince K, et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis[J]. Cancer,2001,92:2523. 被引量:1
  • 7Sidoni A, Cavaliere A, Bellezza G, et al. Breast cancer in young women: clinicopathological features and biological specificity[ J] . The Breast,2003,12:247. 被引量:1
  • 8Mafia A, De Jesus, Mihoko F, et al. Retrospective analysis of breast cancer among young African American females [ J]. Breast Cancer Research and Treatment,2003,78:81. 被引量:1

二级参考文献11

共引文献43

同被引文献103

  • 1刘万花,郑凯尔,金爱萍,张元宁,何杰,姚青.全数字化乳腺摄影对妇女致密型乳腺病变的诊断价值[J].中华放射学杂志,2006,40(4):350-353. 被引量:21
  • 2张嘉庆,程琳.家族性乳腺癌的研究现状[J].中华肿瘤防治杂志,2006,13(16):1201-1204. 被引量:6
  • 3<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 4孟洁,郎荣刚,范宇,付丽.年轻乳腺癌患者的病理学和生物学特征及其与预后的关系[J].中华肿瘤杂志,2007,29(4):284-288. 被引量:29
  • 5Fuqua SA, Schiff R, Parra I, et al. Estrogen receptor βprotein in human breast cancer; correlation with clinical tumor parameters [J]. Cancer Res,2003 ,63 :2434. 被引量:1
  • 6Nakopoulou L, Lazaris AC, Panayotopoulou EC, et al. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer [J]. J Clin Pathol, 2004,57 : 523. 被引量:1
  • 7Adedayo A Onitilo, Jessica M Engel, Robert T Greenlee, et al. Breast cancer subtypes based on ER/PR and Her2 Ex pression : comparison of clinicopathologic features and sur-vival[J]. Clin Med Res,2009 ,7 :4. 被引量:1
  • 8Slamon OJ, Clsrk CM, Wang SG, et al. Human breast cancer,correlation of relapse and survival with amplification of the Her-2/neu oncogene [J]. Science, 1987,235 : 177. 被引量:1
  • 9Burcombe RJ, Makris A, Richman PI, et al. Evaluation of ER. PR HER-2 and Ki-67 as predictors of response to neoadjuvant anthracyline chemotherapy for operable breast Cancer [J]. Br J Cancer,2005,92( 1 ) : 147. 被引量:1
  • 10Di Giovanna MP, Stern OF, Edgerton SM, et al. Relationship of epidermal growth factor receptor expression to C-erbB-2 signaling activity and prognosis in breast cancer patients [J]. J Clin Oncol,2005,23 ( 6 ) : 1152. 被引量:1

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部